UPDATE: 3/29/2021 9 am – Upgrade completed at 2 am, queued results are going outbound and acknowledgements are being returned successfully by external systems. If you have any issues or concerns, please use the contact us link above or call the Spectrum Health Helpdesk at 616-391-4357, Option 3 and reference the Change request number: CHG0056123
Beginning Sunday, March 28th at 22:00 (10 pm), eSHare, the system that handles interfaced laboratory orders and results between various practice EMRs (Electronic Medical Record) and the Spectrum Health West Michigan Epic system, will be down to upgrade the software to a newer version. During this downtime, orders and results will not pass from eSHare to Epic or vice versa. These will queue up and release once the upgrade is completed. The downtime is expected to end on March 29th at 02:00 (2 am).
This does not affect Epic (“Hyperspace”), EpicCare Link (“Link”), or Epic Community Connect (formerly Epic Affiliate Program).
If you have questions or concerns, please use the Contact Us link above.
Effective May 20, 2019, Spectrum Health Regional Laboratory Cytogenetics Department is pleased to announce the launch of a new microarray platform AffymetrixTM Cytoscan® HD. The Affymetrix Cytoscan HD is designed for the accurate and comprehensive analysis of chromosomal variants in the human genome.
To remain up to date with the scientific literature, microbiology must periodically update the official taxonomic nomenclature for organisms as published in the International Journal of Systematic and Evolutionary Microbiology (IJSEM). These updates also satisfy the laboratory’s accreditation checklist item MIC.11375 from the College of American Pathologists (CAP). Current organism classification is typically revised based on genetic relatedness among genera and species, as opposed to historical phenotypic biochemical characteristic studies.
In mid-September 2017, Spectrum Health Regional Laboratory Immunology department in collaboration with Spectrum Health Adult and Pediatric Rheumatology have made some adjustments to antinuclear antibody (ANA) testing (see below) options.